Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to ETFdb.com. Please help us personalize your experience.

Select the one that best describes you

Biggest Commodity ETFs to Add to Your Portfolio

Etfdb logo
  • ETF
  • FXH
    Pricing Data
    Change: $0.44 (-0.01%)
    Time: 06/26/17
    Previous Close: $68.05
  • Category
  • Health & Biotech Equities
Last Updated:



Trading Data

Open: - Volume -
Day Lo - Day Hi -
  • 52 Week Lo: $54.51
  • 52 Week Hi: $68.34
  • AUM: $1,061.1 M
  • Shares: 15.6 M

Investment Themes

Historical Trading Data

  • 1 Month Avg. Volume: 78,638
  • 3 Month Avg. Volume: 95,645

Alternative ETFs in the Health & Biotech Equities Category

Sign Up for Pro to Unlock Data Sign Up
Type Ticker Expense Ratio Assets Avg. Daily Vol YTD Return
Largest (AUM)
Most Liquid (Volume)
Top YTD Performer

Analyst Report

This ETF offers exposure to the U.S. health care sector, making it one of many options for accessing a corner of the market that is generally stable and can offer attractive dividends. Given the sector-specific focus, FXH likely doesn't deserve a core allocation, but may be useful as a means of implementing a tactical tilt towards the health care sector. FXH seeks to replicate an index that employs a unique strategy designed to generate excess returns relative to traditional cap-weighted benchmarks. The underlying AlphaDEX Index employs a quant-based screening methodology designed to identify stocks poised for outperformance. In return for exposure to this strategy, which has historically delivered impressive returns, investors can expect to pay a bit more; FXH's expense ratio is about 50 basis points higher than low cost options for health care exposure such as FHC and XLV. The unique index construction methodology has some other potential advantages; FXH maintains a much lower concentration of top holdings than do cap-weighted funds such as XLF. That means that performance isn't as dependent on a handful of large cap stocks, potentially giving a better way to access health care stocks. For those who believe in the merits of the AlphaDEX methodology and are willing to pay a little extra for a shot at alpha, FXH might be worth a closer look. Those looking to keep a cap on expenses and simply own the broader market have cheaper options available to them.

Realtime Rating

Sign Up for Pro to Unlock Data Sign Up

Realtime Rating Summary

The adjacent table gives investors an individual Realtime Rating for FXH on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

Compare to another ETF

View the Category Report

FXH Overall Realtime Rating:

A+ Overall Rated ETF:

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity A n/a
Expenses C+ n/a

Knowledge Centers

FXH In-Depth Analysis

The following tables and charts contain in-depth metrics for this ETF and compare it to similar peer ETFs within its ETFdb.com Category.

FXH Holdings

Filings Data as of: Jun 23, 2017

Concentration Analysis

This section compares how balanced and deep this ETF is relative to the peer group ETFdb.com Category.

Number of Holdings
Category Low
Category High
% Assets in Top 10
Category Low
Category High
% Assets in Top 15
Category Low
Category High
% Assets in Top 50
Category Low
Category High

Asset Allocation

Asset Percentage
Common equity 99.99%
ETF Cash Component 0.01%

Sector Breakdown

Sector Percentage
Healthcare 99.17%
Industrials 0.82%
ETF Cash Component 0.01%

Market Cap Breakdown

Market Cap Percentage
Large cap 48.47%
Mid cap 39.63%
Small cap 9.83%
Micro cap 2.06%
ETF Cash Component 0.01%

Region Breakdown

Region Percentage
North America 98.37%
Europe 1.63%

Market Tier Breakdown

Region Percentage
United States 98.37%
Developed Markets (ex-US) 1.63%

Country Breakdown

Country Percentage
United States 98.37%
Ireland 1.63%

FXH Expenses & Fees

This section compares the cost efficiency of this ETF to peers in the same ETFdb.com Category.

Sign Up for Pro to Unlock Data Sign Up

Expenses Ratio Analysis

ETF Average
ETF Wtd. Average
Category Average
Expense Ratio
Category Low
Category High

Commission Free Trading

This ETF is not currently available for commission free trading on any platforms.

Category Commission Free Trading

There are 3 other ETFs in the Health & Biotech Equities ETFdb.com Category that are also eligible for commission free trading:

FXH Performance

This section shows how this ETF has performed relative to its peer group ETFdb.com Category.

1 Week Return
Category Low
Category High
4 Week Return
Category Low
Category High
13 Week Return
Category Low
Category High
26 Week Return
Category Low
Category High
Year to Date Return
Category Low
Category High
1 Year Return
Category Low
Category High
3 Year Return
Category Low
Category High
5 Year Return
Category Low
Category High

Brought to You by Mitre Media


The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.

The following chart also includes the option to compare the performance of FXH relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.

FXH Valuation

This section shows how the P/E multiple of this ETF compares to the peer group ETFdb.com Category.

Sign Up for Pro to Unlock Data Sign Up
P/E Ratio
Category Low
Category High

FXH Dividend

This section shows how the dividend yield of this ETF compares to the peer group ETFdb.com Category.

Sign Up for Pro to Unlock Data Sign Up
Dividend Date
Annual Dividend Rate
Annual Dividend Yield
Category Low
Category High

FXH Technicals

Sign Up for Pro to Unlock Data Sign Up

Volatility Analysis

This section shows how the volatility of this ETF compares to the peer group ETFdb.com Category.

5 Day Volatility
Category Low
Category High
20 Day Volatility
Category Low
Category High
50 Day Volatility
Category Low
Category High
200 Day Volatility
Category Low
Category High
Category Low
Category High
Standard Deviation
Category Low
Category High


  • 20 Day MA: $66.00
  • 60 Day MA: $64.04
  • MACD 15 Period: 1.32
  • MACD 100 Period: 4.38
  • Williams % Range 10 Day: 23.03
  • Williams % Range 20 Day: 17.42
  • RSI 10 Day: 72
  • RSI 20 Day: 70
  • RSI 30 Day: 67
  • Ultimate Oscillator: 67

Bollinger Brands

  • Lower Bollinger (10 Day): $64.67
  • Upper Bollinger (10 Day): $68.51
  • Lower Bollinger (20 Day): $63.96
  • Upper Bollinger (20 Day): $67.93
  • Lower Bollinger (30 Day): $62.55
  • Upper Bollinger (30 Day): $67.90

Support & Resistance

  • Support Level 1: $67.37
  • Support Level 2: $67.13
  • Resistance Level 1: $67.96
  • Resistance Level 2: $68.31


  • Stochastic Oscillator %D (1 Day): 55.98
  • Stochastic Oscillator %D (5 Day): 79.15
  • Stochastic Oscillator %K (1 Day): 68.22
  • Stochastic Oscillator %K (5 Day): 80.70

Fact Sheet

Fact sheets are issued by the ETF provider and framed by ETFdb.com. Information contained within the fact sheet is not guaranteed to be timely or accurate.

Source: LSEG Information Services (US), Inc. (“LSEG”) © LSEG 2016. All rights in the XTF data, ratings and / or underlying data contained in this communication (“the XTF information”) vest in LSEG and/or its licensors. Neither LSEG nor its licensors accept any liability arising out of the use of, reliance on or any errors or omissions in the XTF information. No further distribution of the XTF information is permitted without LSEG’s express written consent. LSEG does not promote, sponsor or endorse the content of this communication.